Systemic leukofiltration does not attenuate pulmonary injury after cardiopulmonary bypass.
Pulmonary injury mediated by activated leukocytes is a recognized complication of cardiopulmonary bypass. The aim of this paper is to systematically analyze the effects of systemic leukofiltration within the cardiopulmonary bypass circuit on pulmonary injury and related clinical outcomes. We perform...
Principais autores: | Warren, O, Tunnicliffe, C, Massey, R, Wallace, S, Smith, A, Alcock, E, Darzi, A, Vincent, C, Athanasiou, T |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2008
|
Registros relacionados
-
The inflammatory response to cardiopulmonary bypass: part 1--mechanisms of pathogenesis.
por: Warren, O, et al.
Publicado em: (2009) -
The inflammatory response to cardiopulmonary bypass: part 2--anti-inflammatory therapeutic strategies.
por: Warren, O, et al.
Publicado em: (2009) -
Remote ischemic preconditioning attenuates cardiopulmonary bypass-induced lung injury.
por: Xiaona Zhou, et al.
Publicado em: (2017-01-01) -
The neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass
por: Tuo Pan, et al.
Publicado em: (2023-01-01) -
Skeletonization of radial and gastroepiploic conduits in coronary artery bypass surgery
por: Darzi Ara, et al.
Publicado em: (2007-06-01)